• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Tokyo Startup Bisu Raises $3.2M for ‘Lab-On-A-Chip’ Urine and Saliva Analyzer

by Fred Pennic 10/07/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Tokyo Startup Bisu Raises $3.2M for 'Lab-On-A-Chip' Urine and Saliva Analyzer

What You Should Know:

– Bisu, Inc., a  Tokyo-based digital health startup that helps people improve their health and wellness through lab-grade testing at home, today announced ­$3.2M in seed funding led by Korean biotech investor QUAD, with participation from ASI­CS Ventures Corporation, 15th Rock Ventures, Pacifico Investments, and SOSV.

– The funding will enable Bisu to bring to market Bisu Body Coach, a portable “home health lab” for personalized nutrition and lifestyle advice through easy, accurate urine and saliva testing. Bisu also reached an agreement with ASICS Corporation to collaborate on health and fitness service initiatives.

Bisu Body Coach: Bringing the Lab to Your Home

Bisu Body Coach consists of a disposable test stick and a reader that syncs with a companion smartphone app. The microfluidic “lab-on-a-chip” technology used in the test stick enables reliable, precise and automated measurements of a wide range of biomarkers in just two minutes. The app provides feedback on key nutrition indicators such as hydration, minerals and vitamins, and recommendations are personalized based on the user’s goals, dietary preferences, activity, sleep and weight. 

Bisu Body Coach Availability & Pipeline

Bisu Body Coach is currently in beta, with a pipeline of additional test sticks covering training intensity, hormones, and pet and baby health. Bisu and ASICS will work together on future initiatives aimed to enhance personal health and athletic performance. ASICS’ investment follows Bisu’s victory in the U.S. Sports & Fitness Industry Association’s startup competition — one of the industry’s major events for which more than 100 sports and fitness executives served as judges.

“This funding is a major vote of confidence from a group of investors who are both tech-savvy, consumer-focused and globally minded,” says Daniel Maggs, Co-founder & CEO at Bisu. “We are delighted to announce our collaboration with ASICS. ASICS shares our passion for making beautiful yet scientifically rigorous products in the spirit of Japanese craftsmanship, yet is also a modern, globally-recognized brand,” says Wojciech Bula, PhD, Co-founder & CTO.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |